Biogen Inc. (LON:0R1B)

Singular Genomics Systems Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,996	17,799	29,437	33,096	26,027	27,598
Market Cap Growth	-49.71%	-39.53%	-11.06%	27.16%	-5.69%	-31.73%
Enterprise Value	16,856	21,755	33,694	33,805	29,090	29,964
Last Close Price	95.86	121.22	258.40	273.09	242.15	242.20
PE Ratio	12.53	13.65	32.29	13.09	22.65	9.42
PS Ratio	1.92	2.30	3.81	3.92	3.21	2.80
PB Ratio	1.09	1.33	2.53	2.98	3.22	3.53
P/TBV Ratio	11.46	40.82	172.63	6.88	12.10	20.32
P/FCF Ratio	-	8.19	29.52	34.86	10.42	9.90
P/OCF Ratio	-	7.75	24.23	28.81	9.68	8.91
EV/Sales Ratio	2.26	2.82	4.36	4.00	3.59	3.04
EV/EBITDA Ratio	6.77	9.09	18.06	11.52	10.04	8.01
EV/EBIT Ratio	9.12	11.73	22.80	13.49	11.47	8.80
EV/FCF Ratio	11.67	10.01	33.79	35.60	11.65	10.75
Debt / Equity Ratio	0.37	0.40	0.50	0.50	0.70	0.74
Debt / EBITDA Ratio	1.97	2.15	2.95	1.85	1.91	1.52
Debt / FCF Ratio	3.33	2.47	5.85	5.87	2.28	2.08
Asset Turnover	0.36	0.35	0.38	0.42	0.45	0.52
Inventory Turnover	1.02	0.93	1.31	1.69	1.74	1.93
Quick Ratio	1.52	0.77	1.04	2.39	1.34	1.32
Current Ratio	2.50	1.35	2.00	2.99	1.83	1.84
Return on Equity (ROE)	9.13%	10.36%	8.24%	24.33%	15.96%	33.80%
Return on Assets (ROA)	5.62%	5.29%	4.58%	7.79%	8.86%	11.21%
Return on Capital (ROIC)	6.62%	6.36%	5.56%	9.74%	11.53%	15.15%
Return on Capital Employed (ROCE)	9.90%	10.30%	8.00%	14.20%	17.50%	22.30%
Earnings Yield	7.98%	7.32%	3.10%	7.64%	4.42%	10.62%
FCF Yield	10.32%	12.21%	3.39%	2.87%	9.60%	10.10%
Buyback Yield / Dilution	-0.31%	-0.21%	0.27%	2.41%	7.25%	13.93%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.